hwa 138 has been researched along with E coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bengtsson, A; Högåsen, K; Mollnes, TE; Redl, H; Schlag, G | 1 |
| Fujishima, S; Hatherill, JR; Hoffmann, H; Ishizaka, A; Raffin, TA; Yonemaru, M; Zheng, H | 1 |
2 other study(ies) available for hwa 138 and E coli Infections
| Article | Year |
|---|---|
Effects on complement activation and cytokine (TNF-alpha and IL-8) release of infusion of anti-TNF-antibodies or a xanthine derivative (HWA 138) in septic baboons.
Topics: Animals; Antibodies; Complement Activation; Complement Membrane Attack Complex; Escherichia coli Infections; Hemodynamics; Interleukin-8; Male; Papio; Pentoxifylline; Sepsis; Tumor Necrosis Factor-alpha; Xanthines | 1996 |
Attenuation of acute lung injury in septic guinea-pigs by a new xanthine derivative (HWA-138).
Topics: Acute Disease; Animals; Blood Pressure; Bronchodilator Agents; Erythrocytes; Escherichia coli Infections; Guinea Pigs; Injections, Intravenous; Iodine Radioisotopes; Leukocyte Count; Lung Diseases; Pentoxifylline; Respiratory Tract Infections; Theobromine | 1989 |